Clinical trial
Molecular Staging of Endometrial Cancer
NCT00340808 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00340808 |
|---|---|
| Title | Molecular Staging of Endometrial Cancer |
| Official title | Integration of an Epidemiologic Questionnaire Into Gynecologic Oncology Group Trials: First Project, Protocol 210 |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Endometrial Cancer |
| Enrollment | 5,492 |
| Start date | Mar 19, 2004 |
| Primary completion | Jun 30, 2020 |
| Completion | Jul 16, 2020 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 17, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: